Giant Eagle Pharmacy #6381 Pharmacy Location: 36475 Euclid Ave, Willoughby, Ohio 44094 Phone: (440) 946-7714 |
Cvs Pharmacy #04351 Durable Medical Equipment & Medical Supplies Location: 6005 Som Center Rd, Willoughby, Ohio 44094 Phone: (440) 946-7252 |
Rite Aid Pharmacy 03011 Durable Medical Equipment & Medical Supplies Location: 36212 Euclid Ave, Willoughby, Ohio 44094 Phone: (440) 942-4288 |
Cvs Pharmacy #16484 Durable Medical Equipment & Medical Supplies Location: 36195 Euclid Ave, Willoughby, Ohio 44094 Phone: (440) 975-1983 |
Walgreens #4294 Durable Medical Equipment & Medical Supplies Location: 5881 Som Center Rd, Willoughby, Ohio 44094 Phone: (440) 946-4357 |
Terrys Shoes Footcare Center Durable Medical Equipment & Medical Supplies Location: 36301 Euclid Ave, Willoughby, Ohio 44094 Phone: (440) 975-9834 |
Mark F Kapusta Od Inc Medicare Supplier Location: 30851 Euclid Ave, Willoughby, Ohio 44094 Phone: (440) 944-5155 |
News Archive
Researchers at the UCLA Jonsson Comprehensive Cancer Center have identified a new drug delivery pathway that may help stop tumor growth and keep cancer from coming back in mice.
A study published recently in the Annals of Thoracic Surgery shows a 45% reduction in operative mortality in high risk patients requiring aortic valve replacement when Least Invasive Valve techniques are used compared to the conventional approach.
Revenues in most U.S. states increased in the fourth quarter of 2011, but their recent surge is tapering off, as they grew just 2.7 percent from the final quarter of 2010, according to a report released on Monday. "This is a noticeable slowdown from the 11.1 (percent) and 6.1 percent year-over-year growth reported in the second and third quarters of 2011, respectively," the Rockefeller Institute, a think tank that closely watches states' revenues, said in the report.
A Canadian research team at the IRCM in Montreal, led by molecular virologist Eric A. Cohen, PhD, made a significant discovery on how HIV escapes the body's antiviral responses. The team uncovered how an HIV viral protein known as Vpu tricks the immune system by using its own regulatory process to evade the host's first line of defence.
Auxilium Pharmaceuticals, Inc., a fully integrated specialty biopharmaceutical company, announced today that the U.S. Food and Drug Administration has approved XIAFLEX (collagenase clostridium histolyticum, or CCH), an in-office, biologic for the treatment of Peyronie's disease. XIAFLEX is the first and only FDA-approved treatment proven effective for PD in men with a palpable plaque and a curvature deformity of 30 degrees or greater at the start of therapy.
› Verified 3 days ago